Comparing the evolution and expression of anxiety assessed with spence children anxiety scale (SCAS) in paediatric patients prescribed Calcarea group of remedies : A prospective case series study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 27
- 试验地点
- 1
- 主要终点
- To compare the evolutionary patterns and expressions of anxiety assessed
研究概览
简要总结
A study on how anxiety evolves in a child and how it expresses in children taking calcarea group of remedies and observing the changes in anxiety using spence children anxiety scale We will select children from ages 7 to 17 and then compare how anxiety evolves and expressed in them First we will use Spence children anxiety scale and understand which calcarea group of remedies he belongs to. If he falls under it then we will prescribe the medicine and understand how anxiety evolves and expresses in him.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 7.00 Year(s) 至 17.00 Year(s)（—）
- 性别
- All
入选标准
- •Age Range 7 to 17 years of age.
- •Treatment Children who have received treatment with the above calcarea group of remedies
- •Children whose T score is less than or equal to 65(showing signs of normal to elevated levels of anxiety but not necessarily in clinical range) according to spence children anxiety scale SCAS.
- •Children whose overall improvement is assessed using MONARCH Modified Naranjo Criteria for Homeopathy scale.
- •Cases in which parents will give assent for their child.
排除标准
- •Children who are diagnosed with anxiety disorders.
结局指标
主要结局
To compare the evolutionary patterns and expressions of anxiety assessed
时间窗: SCAS 0 weeks during screening | MONARCH 3 months used to assess overall improvement
using SCAS (Spence children’s anxiety scale) in children prescribed
时间窗: SCAS 0 weeks during screening | MONARCH 3 months used to assess overall improvement
calcarea group of remedies.
时间窗: SCAS 0 weeks during screening | MONARCH 3 months used to assess overall improvement
次要结局
- NA(NA)